Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


2012 Scrip Asia 100: Withered in Oz, a tale of research rejuvenation

This article was originally published in Scrip

Executive Summary

Despite its small market size, Australia has traditionally attracted more than its fair share of international clinical trials. But business hasn’t been so good over the last few years. The number of new trials conducted in the country fell by 34% between 2007 and 2010, and yet investment in clinical trials globally continued to climb during this time.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts